20.83

1.17% 0.24

After Hours: 20.60 -0.23 -1.10%

Embecta Corp (EMBC)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Embecta Corp stock is traded at $20.83, with a volume of 348.69K. It is up +1.17% in the last 24 hours and up +43.95% over the past month. Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Previous Close:

$20.59

Open:

$20.16

24h Volume:

348.69K

Relative Volume:

0.93

Market Cap:

$1.20B

Revenue:

$1.12B

Net Income/Loss:

$55.30M

P/E Ratio:

25.72

EPS:

0.81

Net Cash Flow:

$-30.30M

1W Performance:

+50.72%

1M Performance:

+43.95%

6M Performance:

+63.50%

1Y Performance:

+15.08%

1-Day Range:

$19.75

$20.86

1-Week Range:

$13.90

$20.86

52-Week Range:

$9.925

$20.86

Embecta Corp Stock (EMBC) Company Profile

Name

Embecta Corp

Sector

Healthcare (1180)

Industry

Medical Instruments & Supplies (58)

Phone

(862) 401-0000

Address

1209 ORANGE STREET, WILMINGTON

Employee

2,200

Twitter

Next Earnings Date

2024-12-26

Latest SEC Filings

EMBC's Discussions on Twitter

Compare EMBC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EMBC Embecta Corp	20.83	1.20B	1.12B	55.30M	-30.30M	0.95
ISRG Intuitive Surgical Inc	542.00	193.05B	7.87B	2.24B	586.00M	6.22
BDX Becton Dickinson Co	221.90	64.77B	20.18B	1.71B	3.07B	5.94
ALC Alcon Inc	88.85	43.95B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	249.02	36.58B	4.81B	1.11B	1.35B	7.55
WST West Pharmaceutical Services Inc	325.68	23.63B	2.88B	499.60M	321.60M	6.74

Embecta Corp Stock (EMBC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight
Jun-21-22	Initiated	BofA Securities	Underperform

View All

Embecta Corp Stock (EMBC) Latest News

01:39 AM

Embecta sees FY25 adjusted EPS $2.70-$2.90, consensus $2.27 - MSN

01:39 AM

12:32 PM

Embecta (NASDAQ:EMBC) Shares Gap DownWhat's Next? - MarketBeat

12:32 PM

Nov 29, 2024

Isthmus Partners LLC Has $1.56 Million Stock Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat

Nov 29, 2024

Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)? - Yahoo Finance

Nov 29, 2024

Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15 - Simply Wall St

Nov 29, 2024

Algert Global LLC Has $1.48 Million Holdings in Embecta Corp. (NASDAQ:EMBC) - MarketBeat

Nov 29, 2024

Nov 28, 2024

Embecta stock outlook brightens with Buy rating on strategic focus and global footprint - Investing.com Canada

Nov 27, 2024

Embecta Corp. Reports Earnings Results for the Full Year Ended September 30, 2024 - Marketscreener.com

Nov 27, 2024

This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga

Nov 27, 2024

Embecta stock raised to buy at BTIG (EMBC:NASDAQ) - Seeking Alpha

Nov 27, 2024

Embecta stock outlook brightens with Buy rating on strategic focus and global footprint By Investing.com - Investing.com South Africa

Nov 27, 2024

Embecta price target raised to $20 from $17 at BofA - TipRanks

Nov 27, 2024

Rubric Capital Management LP Takes Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat

Nov 27, 2024

Embecta Corp. (NASDAQ:EMBC) Q4 2024 Earnings Call Transcript - Insider Monkey

Nov 27, 2024

BTIG Research Upgrades Embecta (NASDAQ:EMBC) to Buy - MarketBeat

Nov 27, 2024

Embecta to discontinue insulin patch pump program, initiates restructuring plan - MSN

Nov 27, 2024

Embecta upgraded to Buy from Neutral at BTIG - TipRanks

Nov 27, 2024

Embecta earnings beat by $0.09, revenue topped estimates - Investing.com Nigeria

Nov 27, 2024